StreetAlpha.app
Home › Stocks › ESTA

Establishment Labs Holdings Inc. (ESTA)

Healthcare
$69.51
▼ −0.44%
LAST CLOSE · NOV 17

Establishment Labs makes silicone breast implants and related products for plastic surgeons and patients in breast aesthetics and reconstruction. It last closed at $69.51 on Nov 17, down 0.44% on the day. The average 12-month price target from 2 analysts is $94.00 (+35.2% from the last close), with a high of $95.00 and a low of $93.00.

AI Auto Pilots
Is ESTA in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$264.0M
+38.3% vs a year ago
Net income
−$38.5M
−14.6% margin
EPS (diluted)
−$1.27
Free cash flow
−$21.6M
−8.2% margin
Valuation
Market cap
$2.1B
29.8M shares
P/E
–
No P/E while losing money
Price to sales
7.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$75.8M
At Sep 30
Debt
$267.8M
At Sep 30
Shareholder equity
$15.6M
Shares outstanding
29.8M
At Nov 5
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $126.7M$126.7MFY2021FY2022: $161.7M$161.7MFY2022FY2023: $165.2M$165.2MFY2023FY2024: $166.0M$166.0MFY2024FY2025: $211.1M$211.1MFY2025

From ESTA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated ESTA in the past 90 days, not enough for a consensus
Average 12-month target
$94.00
▲ 35.2% upside

Based on 2 analysts who set a price target on ESTA in the past 90 days. The average target is $94.00, with a high of $95.00 and a low of $93.00, compared with the last close of $69.51.

Low $93.00Avg $94.00High $95.00
Blue marker: last close $69.51
Highest target$95.00
Average target$94.00
Lowest target$93.00
Latest rating changes
BTIGTarget lowered
Oct 29Buy$103 → $93
TD CowenTarget lowered
Oct 26Buy$117 → $95
BTIGReiterated
Sep 1Buy$103
JP MorganMaintained
Aug 7Buy$95
NeedhamMaintained
Aug 6Buy$95
DateFirmActionRatingPrice target
Oct 29BTIGTarget loweredBuy$103 → $93
Oct 26TD CowenTarget loweredBuy$117 → $95
Sep 1BTIGReiteratedBuy$103
Aug 7JP MorganMaintainedBuy$95
Aug 6NeedhamMaintainedBuy$95
Loading…

Technical Analysis

ESTA · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend

The stock is 4% above its 20 day and 5% above its 50 day average. It is 4% below its 200 day average, so the longer trend is down. Momentum is strong (RSI 56). The nearest support is the Pivot S1 at $68.66, and the nearest resistance the Pivot at $69.72.

Short trendBullish
Long trendBearish
MomentumStrong
StretchNormal
VolatilityHigh, 5.3%/day
Key levels
$97.5952 week high+40.4%
$74.50100 day average+7.2%
$72.39200 day average+4.1%
$71.88Swing high (Oct 29)+3.4%
$70.58Pivot R1+1.5%
$69.72Pivot+0.3%
$69.51Last close
$68.66Pivot S1−1.2%
$67.12Swing low (Aug 31)−3.4%
$66.4120 day average−4.5%
$65.8350 day average−5.3%
$53.1652 week low−23.5%
Indicators
RSI (14)56.00Middle of its rangeNeutral
MACD1.33Above its signal lineBullish
Stochastic84.1Near the top of its rangeOverbought
ADX (14)20.1Weak trend
Williams %R-20.4Oversold below −80, overbought above −20Neutral
CCI (20)96.0Oversold below −100, overbought above 100Neutral
Rate of change+13.2%Change over 10 sessionsBullish
ATR (14)$3.71Typical daily range, 5.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Below
What happened before, for ESTA

What happened before

See how ESTA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ESTA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ESTA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in ESTA in the last 90 days.

Loading…

See today’s whale options flow across the market →

ESTA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●96 buying vs 102 selling
  • ▼Held by funds -7.6 pts
  • ●Funds holding +0
  • ▲Superinvestors: 4 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1971970.0%
In funds' top 10710−30.0%
Held by funds88.1%95.7%−7.6 pts
New / increased31 / 6555 / 68−22.0%
Reduced / sold out73 / 2949 / 32+25.9%
Put/call ratio0.890.74+19.8%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ESTA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ESTA is in one of them and how their past ESTA trades turned out.

ESTA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ESTA in an article yet. Here's the latest on the wider market.

About Establishment Labs Holdings

Establishment Labs makes breast implants and related products for breast augmentation and reconstruction. Its main line is Motiva Implants, silicone gel filled breast implants registered for sale in many countries. The company also offers the Flora tissue expander and Preservé, a minimally invasive breast tissue preserving technology. It sells through exclusive distributors and its own direct sales force to plastic surgeons and other physicians. The company is based in Alajuela, Costa Rica.

Headquarters
Alajuela, Costa Rica